Improvement of Fertilization Rate and Embryo Quality by Treating Calcium Ionophore in IVF Patients: a Sibling Oocyte Control Study
GM508 in IVF
Improved the Low Fertilization Rates and Increased the High-quality Embryogenesis by Treatment With Calcium Ionophore GM508 CultActive Optimized Medium in Vitro Fertilization (IVF) Patients
1 other identifier
interventional
68
1 country
1
Brief Summary
GM508 CultActive is a bicarbonate buffered reagent and ready-to-use designed to investigate oocytes of patients with failed fertilization after previous Intracytoplasmatic Sperm Injection cycles. The investigators hypothesize that GM508 CultActive will improve the fertilization rate and embryo development of such IVF patients (a history of poor fertilization, a history of poor embryo quality, and over 40 years old expected challenging to conceive).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedMarch 20, 2026
March 1, 2026
2.2 years
November 20, 2022
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
fertilization rate
The normal fertilization rate will defined as the number of zygotes with 2PN and 2PB per the total number of mature oocytes
Day 1
Secondary Outcomes (3)
blastocyst formation rate
Day 5
top-quality blastocyst formation rate
Day 5
pregnancy outcome
1 year
Study Arms (2)
oocytes treated with calcium ionophore
EXPERIMENTALOocytes treated with a ready-to-use ionophore compound (GM508 CultActive, Gynemed) within 15 min after ICSI (or 18 min in IVF). After 15 min of incubation in GM508 CultActive and a thorough washing process, the oocytes subjected to AOA will transfer to the same time-lapse culture dish with the controlled sibling group.
oocytes undergo routine IVF/ICSI protocol
NO INTERVENTIONUntreated control oocytes will immediately place into the time-lapse imaging system, and the culture protocol was routine.
Interventions
The intervention group will be treated with a ready-to-use ionophore medium (GM508 CultActive, Gynemed) within 15 min after ICSI (or 18 min in IVF) based on the situation of sperm. After 15 min of incubation in GM508 CultActive and a thorough washing process, the oocytes will be cultured in the same protocol as the control group.
Eligibility Criteria
You may qualify if:
- Low fertilization rate in previous IVF cycle (\<30%), or
- Poor embryo developmental problems in previous IVF cycle, or
- Diminished ovarian reserve (AMH\<1.2 or AFC\<5) and/or more than 40 y/o.
You may not qualify if:
- Without or just one oocyte picked up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung Memorial Hospital
Kaohsiung City, 123, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2022
First Posted
February 10, 2023
Study Start
January 1, 2023
Primary Completion
March 23, 2025
Study Completion
June 30, 2025
Last Updated
March 20, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share